Literature DB >> 9105691

Stimulation of cyclic AMP-dependent protein kinase in rat atria by (-)-CGP 12177 through an atypical beta-adrenoceptor.

A J Kaumann1, J A Lynham.   

Abstract

Mammalian hearts possess an atypical beta-adrenoceptor (non-beta 1, non-beta 2, non-beta 3) through which (-)-4-(3-t-butylamino-2 -hydroxypropoxy)benzimidazol-2-one ((-)-CGP 12177) causes cardiostimulant effects. Here we showed that (-)-CGP 12177 increased the activity of adenosine 3':5'-cyclic monophosphate (cyclic AMP)-dependent protein kinase in the presence of 200 nM (-)-propranolol in rat atria at a concentration (10 microM) that elicits maximum positive chronotropic and inotropic effects. The phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine (IBMX) potentiated the positive chronotropic and inotropic effects of (-)-CGP 12177. We suggest that the atypical beta-adrenoceptor is coupled positively to the Gs protein-adenylyl cyclase system.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9105691      PMCID: PMC1564608          DOI: 10.1038/sj.bjp.0701053

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  11 in total

1.  Desensitization and resensitization of beta 1- and putative beta 4-adrenoceptor mediated responses occur in parallel in a rat model of cardiac failure.

Authors:  A R Kompa; R J Summers
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

2.  Putative beta 4-adrenoceptors in rat ventricle mediate increases in contractile force and cell Ca2+: comparison with atrial receptors and relationship to (-)-[3H]-CGP 12177 binding.

Authors:  D Sarsero; P Molenaar; A J Kaumann; N S Freestone
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

3.  Multiple signalling pathways involved in beta2-adrenoceptor-mediated glucose uptake in rat skeletal muscle cells.

Authors:  Julia Nevzorova; Bronwyn A Evans; Tore Bengtsson; Roger J Summers
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

4.  Phosphodiesterase PDE3 blunts the positive inotropic and cyclic AMP enhancing effects of CGP12177 but not of noradrenaline in rat ventricle.

Authors:  Maria Luisa Vargas; Jesus Hernandez; Alberto J Kaumann
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

5.  The effects of both noradrenaline and CGP12177, mediated through human beta1 -adrenoceptors, are reduced by PDE3 in human atrium but PDE4 in CHO cells.

Authors:  Alberto Kaumann; Annalese B T Semmler; Peter Molenaar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-02-21       Impact factor: 3.000

6.  Impairment of the low-affinity state beta1-adrenoceptor-induced relaxation in spontaneously hypertensive rats.

Authors:  Mohamed Yassine Mallem; Gilles Toumaniantz; Sabrina Serpillon; Freddy Gautier; Marc Gogny; Jean-Claude Desfontis; Chantal Gauthier
Journal:  Br J Pharmacol       Date:  2004-10-04       Impact factor: 8.739

7.  Overexpression of beta 1-adrenoceptors in adult rat ventricular myocytes enhances CGP 12177A cardiostimulation: implications for 'putative' beta 4-adrenoceptor pharmacology.

Authors:  Clive J Lewis; Haibin Gong; Morris J Brown; Sian E Harding
Journal:  Br J Pharmacol       Date:  2004-02-02       Impact factor: 8.739

8.  Binding of (-)-[3H]-CGP12177 at two sites in recombinant human beta 1-adrenoceptors and interaction with beta-blockers.

Authors:  Shirin S Joseph; James A Lynham; William H Colledge; Alberto J Kaumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-04-02       Impact factor: 3.000

9.  Chronic activation of the low affinity site of β1-adrenoceptors stimulates haemodynamics but exacerbates pressure-overload cardiac remodelling.

Authors:  Helen Kiriazis; Niquita Tugiono; Qi Xu; Xiao-Ming Gao; Nicole L Jennings; Ziqui Ming; Yidan Su; Paul Klenowski; Roger J Summers; Alberto Kaumann; Peter Molenaar; Xiao-Jun Du
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

10.  Markedly reduced effects of (-)-isoprenaline but not of (-)-CGP12177 and unchanged affinity of beta-blockers at Gly389-beta1-adrenoceptors compared to Arg389-beta1-adrenoceptors.

Authors:  S S Joseph; J A Lynham; A A Grace; W H Colledge; A J Kaumann
Journal:  Br J Pharmacol       Date:  2004-03-22       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.